Core Medical Publishing
Home About Us Products & Services
Frequently Asked Questions Contact Us Privacy Policy
Publishing
Core Evidence
Editorial
Aims and Scope
Features and Benefits
Online Early
Current Issue
Previous Issues
Future Issues
Free Trial
Subscribe
Permissions and Reprints
Editorial Information
Call For Papers
Continuing Medical Education
New CME Activities
MedicVision
MedicVision

Online Early
Online Early
Free Trial
Free Trial
Sample Sample
Current Issue

Vol. 2, No. 3 February, 2008

Contents
Infliximab: the evidence for its place in therapy in ulcerative colitis
Abatacept: the evidence for its place in the treatment of rheumatoid arthritis
Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome
Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
Eritoran: the evidence of its therapeutic potential in sepsis
Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Alternatively, to subscribe to Core Evidence, please click here
HOME  |  ABOUT US   |  PRODUCTS & SERVICES  |  FAQ  |  CONTACT US  |  PRIVACY POLICY
| Terms and conditions